According to information from the Shenzhen Stock Exchange, on August 26, *ST Bikang issued 19 announcements in succession, which were related to the interim report performance and the resignation of executives
.
Among them, the 2022 semi-annual report shows that during the reporting period, the company's 2022 semi-annual operating income was 3.
993 billion yuan, a year-on-year increase of 15.
76%; net profit attributable to the parent was 324 million yuan, a year-on-year increase of 6.
65%; basic earnings per share was 0.
21 yuan
.
The announcement shows that the company's main business is new energy, new materials, pharmaceutical intermediates, pharmaceutical business, and pharmaceutical industry
.
Among them, in terms of new energy and new materials, the production capacity of Jiujiujiu Technology's ultra-high molecular weight polyethylene fiber, lithium hexafluorophosphate, and its subsidiary Jiujiujiu's ultra-high molecular weight polyethylene fiber non-woven fabric production capacity ranks first in China front row
.
In addition, during the reporting period, the company continued to deploy the pharmaceutical business field, promoted the construction of a pharmaceutical business system, continued to promote business cooperation with Guangdong, Anhui, Shandong, Heilongjiang, Gansu and other regions, and continuously strengthened its resource integration capabilities to enhance the company's development in the business field.
space
.
The company has acquired commercial enterprises, whose business covers Hebei, Henan and other provinces
.
On the same day, *ST Bikang also announced a number of notices of personnel changes, including: Mr.
Tian Qian, the independent director of the company, and Mr.
Shui, the party chairman, applied to resign from the company's fifth session of the board of directors and related positions of the special committee of the board of directors due to personal reasons
.
After resigning from the above-mentioned positions, Mr.
Tian Qian and Mr.
Party Chairman Shui will not hold any positions in the company; Huang Zemin, Qian Shanguo, Liu Congyuan and other candidates for independent directors of the fifth board of directors of the company issued a public statement; nominated Mr.
Hu Shaoan as the fifth board of directors of the company The term of the non-independent director candidate is the same as the term of the fifth session of the board of directors; the chairman of the company, Mr.
Han Wenxiong, nominated Mr.
Liu Chang as the secretary of the company's board of directors, and the term of office is consistent with the term of the fifth session of the board of directors
.
After Mr.
Liu Chang's appointment as secretary to the board of directors took effect, Mr.
Han Wenxiong no longer acted as secretary to the board of directors and continued to serve as the chairman of the company
.
In addition, on the same day, *ST Bikang also issued an announcement that it had received a civil mediation letter.
The litigation mediation showed that the defendant, Yan'an Bikang, made a one-time payment to the plaintiff Yan'an Urban Construction Investment (Group) Co.
, Ltd.
before August 26, 2022.
A principal of 198 million yuan was paid; the defendants Xinyi Bikang New Pharmaceutical Industry Complex Investment Co.
, Ltd.
and Li Zongsong assumed joint and several liability guarantees for the above principal; The second-rank mortgage-guaranteed houses of the Company shall be paid preferentially with the proceeds from the auction and sale of the houses in accordance with the law
.
However, regarding the possible impact of this lawsuit on the company's current or future profits, the company stated that, except for the principal, this case will not have any impact on the company's current or future profits
.
The company will continue to pay attention to the progress of this lawsuit, and timely fulfill its information disclosure obligations in accordance with relevant laws and regulations
.
As of the close on August 25, *ST Bikang closed at 11.
09 yuan, down 1.
86%, with a turnover rate of 3.
82%, a trading volume of 585,200 lots, and a turnover of 655 million yuan
.
In terms of capital flow data, on August 25, the net outflow of main funds was 35.
2047 million yuan, the net inflow of hot funds was 3.
4629 million yuan, and the net inflow of retail funds was 31.
7418 million yuan
.
In terms of margin financing and securities lending, the net outflow of financing in the past 5 days was 3.
1576 million, and the financing balance decreased
;
